NHS East Genomics
NHS East Genomics
East Genomics unites patient care teams, scientists, researchers and educators to deliver the benefits of innovative and high quality genomic medicine to communities across the East Midlands and East of England.
East Genomics incorporates:
- East Genomic Laboratory Hub (East GLH)
East GLH provides and coordinates genomic testing for 29 NHS trusts within East of England and East Midlands.
Our lead laboratory, which carries out the majority of tests for the region, is based at Cambridge University Hospitals NHS Foundation Trust. This is supported by local genomic laboratories based at University Hospitals Leicester NHS Trust and Nottingham University Hospitals NHS Trust.
- East Genomic Medicine Service Alliance (East GMSA)
East GMSA has been set up to ensure equity of access to genomic testing across the region.
We are one of seven hubs within England which together make up the National Genomic Medicine Service.
Genomic sequencing delivers high-impact diagnostic answers to patients, ranging from critically ill babies in intensive care to adults newly diagnosed with cancer.
Genomic medicine can transform lives by:
- enabling a quicker diagnosis for patients with a rare disease, rather than years of uncertainty
- matching people to the most effective medications and interventions, reducing the likelihood of an adverse drug reaction
- increasing the number of people surviving cancer each year because of more accurate and early diagnosis and more effective use of therapies.
We provide core genomic testing using a variety of techniques for the diagnosis and monitoring of rare and inherited diseases, haematological malignancies and cancers. The service is designated as a specialist national testing centre for rare genomic diseases in neurology and endocrinology.
We are working to provide equal access to testing and hence timely diagnosis across a population of 8.3 million people. The East Genomic Service Medicine Alliance (East GMSA) has been set up with this as its core mission.